Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program.
about
Allogeneic hematopoietic stem cell transplantation in adult acute lymphoblastic leukemia: potential benefit of medium-dose etoposide conditioningAdvances in haplo-identical stem cell transplantation in adults with high-risk hematological malignanciesMilestones of Hematopoietic Stem Cell Transplantation - From First Human Studies to Current DevelopmentsAlternative Donor Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid LeukemiaThe molecular determination of HLA-Cw alleles in the Mandenka (West Africa) reveals a close genetic relationship between Africans and EuropeansHospital capacity and post-transplant survival after allogeneic bone marrow transplantation: analysis of data from the Japan Society for Hematopoietic Cell Transplantation.MHC haplotype matching for unrelated hematopoietic cell transplantation.Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trialHaemopoietic stem cell transplantation from unrelated donors.Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantationHigh-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantationOutcomes of patients with myeloid malignancies treated with allogeneic hematopoietic stem cell transplantation from matched unrelated donors compared with one human leukocyte antigen mismatched related donors using HLA typing at 10 loci.Genetic variants of human granzyme B predict transplant outcomes after HLA matched unrelated bone marrow transplantation for myeloid malignancies.A genetic variant in the IL-17 promoter is functionally associated with acute graft-versus-host disease after unrelated bone marrow transplantation.Suppression of HLA expression by lentivirus-mediated gene transfer of siRNA cassettes and in vivo chemoselection to enhance hematopoietic stem cell transplantationRisk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1Umbilical cord blood for allogeneic transplantation in children and adults.Genetically haploidentical stem cell transplantation for acute leukemia.Human leukocyte antigen gene polymorphism and the histocompatibility laboratoryUnrelated donor hematopoietic transplantation.Results of unrelated umbilical cord blood hematopoietic stem cell transplantation.Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.High-resolution, high-throughput HLA genotyping by next-generation sequencing.Measuring ambiguity in HLA typing methods.Graft versus host disease in the bone marrow, liver and thymus humanized mouse model.Ethical considerations on preimplantation genetic diagnosis for HLA typing to match a future child as a donor of haematopoietic stem cells to a sibling.HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation.Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes.Tissue typing in support of unrelated hematopoietic cell transplantation.Biological significance of HLA locus matching in unrelated donor bone marrow transplantation.Natural killer receptor repertoires in transplantation.Development of reduced-intensity hematopoietic stem cell transplantation in the National Cancer Center Hospital, Japan.Mapping MHC-resident transplantation determinantsOptimal HLA matching in hematopoietic cell transplantation.Relative expression levels of the HLA class-I proteins in normal and HIV-infected cells.How does variability of immune system genes affect placentation?Cost-efficient multiplex PCR for routine genotyping of up to nine classical HLA loci in a single analytical run of multiple samples by next generation sequencing.Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia.New insights into haematopoietic stem cell transplantation for patients with haemoglobinopathies.Nonmyeloablative allogeneic stem cell transplantation using alternative donors.
P2860
Q26795740-E16B8DCD-38D8-42D6-95F0-24DD9DB7BA7FQ27014857-30DB2684-7DD6-4004-B6B0-2A848C280112Q28067102-E21C0E3F-6401-422B-83F8-F2E03A7C22E0Q28080943-AE0A9DCC-DA36-4839-BC7B-520D33C19361Q28138939-ADDB0D0B-64A8-494C-91B5-A751DD3F9CF9Q30620615-E3CF6C49-3A32-4D61-B824-395DF6D959D8Q33279672-4272D0B2-ECA9-4258-9B0E-29DE2F4D29F4Q33653406-CD5B6F92-ECA1-4DB2-9339-CBFF8DEBA051Q33656177-F242E059-0E3A-4030-81DE-6AE4BACC1FE0Q33764825-462798EC-E6B0-4224-A0EA-26C1350B9701Q33941128-8DE739D1-7BD8-47D3-B95C-A41B35DECFF7Q33956045-5CAE1DB7-183F-4FC8-BE9F-22CEE648F48FQ34008970-AD364062-3E8C-49AD-A225-8D18242204A3Q34058468-99A6F1F3-89D2-4D4E-9135-442D20C03EB8Q34124667-F998E5BE-2709-4057-AA62-3F0553CF43C5Q34135396-75B008A7-EAD5-4F6E-A672-ECD6A0DC1C6FQ34178470-EDED6D01-F862-4148-8830-CA7281F54C51Q34255634-B76DD3BC-CE61-496C-B7F2-1580663BCD2BQ34326276-5C8BFF1D-BD7B-442D-8610-DA9B320A2369Q34326698-ED8CB413-88B6-414A-B648-C6190B3F518FQ34326722-592FDC5E-F1AD-4C90-BAEF-3FA08FD88253Q34353744-7B20FEB5-22AB-4E58-822D-70FE97019F53Q34380961-113F78C3-E12A-47AF-8663-89D0C5F258B3Q34405338-A98F0C46-A2A0-4A2E-879E-B8D2F6FD5027Q34408266-795AA873-16AE-4AC6-9E54-5F963D91F627Q34547338-74437E1A-9EC1-42B5-998A-0EB50619A5ABQ34768153-16D7B4E6-1938-4A6F-B4FF-AEB72950FF37Q35061893-1F735D3B-54E2-4EA7-9DB9-F7F471B57A85Q35080070-105B143C-850C-453E-BAAE-9A148559CCFEQ35080101-85C5A503-75A0-4F2A-A739-4270B1642F2BQ35145260-AF42E649-7132-4110-A605-54FD9F768C5CQ35201918-F1EAF12E-0A92-4C27-82F4-1114B18C2398Q35237715-E85C5797-EEE8-4D71-80A9-5C5A48BE4BB0Q35237720-033F07CC-A9C4-4140-AC7D-CC296A88757AQ35328953-128515AD-3D6C-4DB3-84CF-47ADC99CD4D5Q35456420-E38D6B83-D001-4A1B-B0ED-208771E5FCEFQ35504310-922B86CD-C265-46FB-AE69-34184DB62B94Q35642826-1A9C79C9-D0E9-4E30-8C9B-A3EDC6E1D5F5Q35688840-02003AD1-3217-40ED-9B82-3D57B0711254Q35692616-39EE8DA6-442F-4222-8EDE-4F7C302682C9
P2860
Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Effect of matching of class I ...... r. Japan Marrow Donor Program.
@en
Effect of matching of class I ...... r. Japan Marrow Donor Program.
@nl
type
label
Effect of matching of class I ...... r. Japan Marrow Donor Program.
@en
Effect of matching of class I ...... r. Japan Marrow Donor Program.
@nl
prefLabel
Effect of matching of class I ...... r. Japan Marrow Donor Program.
@en
Effect of matching of class I ...... r. Japan Marrow Donor Program.
@nl
P2093
P1476
Effect of matching of class I ...... r. Japan Marrow Donor Program.
@en
P2093
Kamikawaji N
Kashiwabara H
Kinukawa N
Morishima Y
Sasazuki T
P304
P356
10.1056/NEJM199810223391701
P407
P577
1998-10-01T00:00:00Z